15 years in the making, Marinus Pharmaceuticals’ first FDA-approved product hits shelves


The product was approved to treat seizure disorders in certain epilepsy patients.

Previous Labcorp to spin off its clinical development business, creating second public company
Next Zero Irving’s newest tenant: Sequoia Capital